Similar articles

• The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease.

  Bannon MJ, Goedert M, Williams B. Bannon MJ, et al. Biochem Pharmacol. 1984 Sep 1;33(17):2697-8. doi: 10.1016/0006-2952(84)90682-8. Biochem Pharmacol. 1984. PMID: 6331828 No abstract available.
• Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?

  Poirier J, Thiffault C. Poirier J, et al. Eur Neurol. 1993;33 Suppl 1:38-43. doi: 10.1159/000118536. Eur Neurol. 1993. PMID: 8375431 Review.
• Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.

  Novikova L, Garris BL, Garris DR, Lau YS. Novikova L, et al. Neuroscience. 2006 Jun 19;140(1):67-76. doi: 10.1016/j.neuroscience.2006.02.007. Epub 2006 Mar 14. Neuroscience. 2006. PMID: 16533572
• [Myeloperoxidase in the neurodegenerative process of Parkinson's disease].

  Teismann P. Teismann P. Dtsch Med Wochenschr. 2014 Jan;139(3):99-102. doi: 10.1055/s-0033-1359907. Epub 2013 Nov 25. Dtsch Med Wochenschr. 2014. PMID: 24277448 Review. German.
• Thirty years of dopamine research.

  Carlsson A. Carlsson A. Adv Neurol. 1993;60:1-10. Adv Neurol. 1993. PMID: 8093570 Review. No abstract available.